epocrates logo
epocrates logo
epocrates logo
  • 0

Interaction Check

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

  • remove Buphenyl
    sodium phenylbutyrate
  • remove Elelyso
    taliglucerase alfa
  • remove Nexviazyme (avalglucosidase alfa-ngpt)
    avalglucosidase alfa
  • remove Nulibry
    fosdenopterin
  • remove Olpruva
    sodium phenylbutyrate
  • remove Palynziq (pegvaliase-pqpz)
    pegvaliase
  • remove Rivfloza
    nedosiran
  • remove sodium phenylbutyrate
    generic
  • remove Vykat XR
    diazoxide choline

multicheck MultiCheck Results - 0 Interaction

Smiley face Smiley face

Additional Considerations

Smiley face Smiley face pegvaliase in Palynziq (pegvaliase-pqpz)

monitor for hypersensitivity reaction (including anaphylaxis) in combo with products containing polyethylene glycol 3350 (PEG 3350) or other PEGylated products (as active or inactive ingredient); combo may incr. risk due to formation of anti PEG IgM and IgG antibodies

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback Cookie Preferences
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information